"Clinical trials have made continuous advances in cancer care over the last several decades. In some instances, control rates have gone from less than 10% to greater than 90% through a succession of trials. Often, patients are only able to receive the most promising new therapies by participation in clinical trials." - Ruby Meredith, MD, PhD
The UAB Department of Radiation Oncology has been successfully partnering with the community for over 40 years to improve care through the careful study of cancer. If you are interested in learning more about our clinical research please view our listing of clinical trials or contact us to learn more about our program.
The Department of Radiation Oncology Clinical Research Program is devoted to the advancement of cancer care through the development of more effective approaches to cancer prevention, diagnosis, and therapy.
In addition to utilizing therapeutic interventions to help prevent and treat cancer in patients locally, our investigators have received funding through the National Institute of Health (NIH) allowing collaborations with national and international investigators. NIH funding was awarded in 2004 and our partnership with a community-based hospital in Mississippi was established and continues to this day with the goal of creating a research program to reduce cancer disparity. The investigators strong interest in the implementation of clinical trials in under-served populations led to a our participation in the NIH funded mentoring program with Zambian health care providers to increase research capacity in Lusaka, Zambia.
We are a full member institution with the Radiation Therapy Oncology Group (RTOG). RTOG is a cooperative effort of physicians, physicists, biologists, and biostatisticians to pursue clinical investigations designed to increase survival and improve the quality of life of patients with cancer. Over 300 academic and community-based facilities in the United States, Canada and internationally participate in RTOG clinical trials, including 90 percent of all NCI-designated comprehensive and clinical cancer centers.
Our ongoing goals are to:
- Foster participation in clinical trials through education and improving public understanding of research.
- Promote human subject protections through compliance with government regulations and good safety practices.
- Provide exceptional service as well as maintain and sustain research integrity.
- To assist in the opening of new clinical trials as well as encourage novel ideas.
- To encourage and seek out collaborations locally, nationally and internationally.
Twelve radiation oncologists are devoted to the clinical investigation of the potential benefits, safety, and efficacy of cancer drugs, biologics, and devices.